The association between monocyte to high-density lipoprotein cholesterol ratio and chronic kidney disease in a Chinese adult population: a cross-sectional study

References

• Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):1–10. doi: 10.1016/S0140-6736(20)30045-3.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 2010;6(5):287–296. doi: 10.1038/nrneph.2010.36.
   PubMed Web of Science ®Google Scholar
• Feingold KR, Grunfeld C, et al. The effect of inflammation and infection on lipids and lipoproteins. In Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
   Google Scholar
• Reis A, Rudnitskaya A, Chariyavilaskul P, et al. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. J Lipid Res. 2015;56(2):413–422. doi: 10.1194/jlr.M055624.
   PubMed Web of Science ®Google Scholar
• Chen H, Chen L, Liu D, et al. Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J Proteome Res. 2017;16(4):1566–1578. doi: 10.1021/acs.jproteome.6b00956.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Moradi H, Yuan J, et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol. 2009;296(6):F1297–F1306. doi: 10.1152/ajprenal.90761.2008.
   PubMed Web of Science ®Google Scholar
• Apostolov EO, Ray D, Savenka AV, et al. Chronic uremia stimulates LDL carbamylation and atherosclerosis. J Am Soc Nephrol. 2010;21(11):1852–1857. doi: 10.1681/ASN.2010040365.
   PubMed Web of Science ®Google Scholar
• Demirbaş A, Elmas ÖF, Atasoy M, et al. Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study. Arch Dermatol Res. 2021;313(6):491–498. doi: 10.1007/s00403-020-02129-3.
   PubMed Web of Science ®Google Scholar
• Canpolat U, Cetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22(5):476–482. doi: 10.1177/1076029615594002.
   PubMed Web of Science ®Google Scholar
• Karatas A, Turkmen E, Erdem E, et al. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy. Biomark Med. 2018;12(9):953–959. doi: 10.2217/bmm-2018-0048.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Dan H, Bai L, et al. Continuous positive linear association between the monocyte to high-density lipoprotein cholesterol ratio and hypertension: a cross-sectional study. Int J Hypertens. 2022;2022:8501726–8501729. doi: 10.1155/2022/8501726.
   PubMed Web of Science ®Google Scholar
• Liu HT, Jiang ZH, Yang ZB, et al. Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies. Medicine (Baltimore). 2022;101(33):e30109. doi: 10.1097/MD.0000000000030109.
   PubMed Web of Science ®Google Scholar
• Chen SA, Zhang MM, Zheng M, et al. The preablation monocyte/high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation. BMC Cardiovasc Disord. 2020;20(1):401. doi: 10.1186/s12872-020-01670-3.
   PubMed Web of Science ®Google Scholar
• Canpolat U. Monocyte-to-HDL-cholesterol ratio and left atrial remodelling in atrial fibrillation. Europace. 2017;19(8):1409–1409. doi: 10.1093/europace/euw195.
   PubMed Web of Science ®Google Scholar
• Huang H, Wang Q, Shi X, et al. Association between monocyte to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a cross-sectional study. Mediators Inflamm. 2021;2021:6642246–6642247. doi: 10.1155/2021/6642246.
   PubMed Web of Science ®Google Scholar
• Wang L, Dong J, Xu M, et al. Association between monocyte to high-density lipoprotein cholesterol ratio and risk of non-alcoholic fatty liver disease: a cross-sectional study. Front Med (Lausanne). 2022;9:898931. doi: 10.3389/fmed.2022.898931.
   PubMed Web of Science ®Google Scholar
• Ekizler FA, Cay S, Açar B, et al. Monocyte to high-density lipoprotein cholesterol ratio predicts adverse cardiac events in patients with hypertrophic cardiomyopathy. Biomark Med. 2019;13(14):1175–1186. doi: 10.2217/bmm-2019-0089.
   PubMed Web of Science ®Google Scholar
• Jiang M, Yang J, Zou H, et al. Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States. Lipids Health Dis. 2022;21(1):30. doi: 10.1186/s12944-022-01638-6.
   PubMed Web of Science ®Google Scholar
• Onalan E. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy. Pak J Med Sci. 2019;35(4):1081–1086. doi: 10.12669/pjms.35.4.534.
   PubMed Web of Science ®Google Scholar
• Shi WR, Wang HY, Chen S, et al. The impact of monocyte to high-density lipoprotein ratio on reduced renal function: insights from a large population. Biomark Med. 2019;13(9):773–783. doi: 10.2217/bmm-2018-0406.
   PubMed Web of Science ®Google Scholar
• Saskin H. Is pre-operative monocyte count-high-density lipoprotein ratio associated with postoperative acute kidney injury in isolated coronary artery bypass grafting? Cardiovasc J Afr. 2022;33:1–7. doi: 10.5830/CVJA-2022-055.
   PubMedGoogle Scholar
• Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310. doi: 10.1001/jamainternmed.2022.6817.
   PubMed Web of Science ®Google Scholar
• Lacquaniti A, Bolignano D, Donato V, et al. Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. Kidney Blood Press Res. 2010;33(2):100–110. doi: 10.1159/000302712.
   PubMed Web of Science ®Google Scholar
• Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the international society of hypertension. J Hypertens. 2014;32(1):3–15. doi: 10.1097/HJH.0000000000000065.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi: 10.2337/dc22-S002.
   PubMedGoogle Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome–a new worldwide definition. Lancet. 2005;366(9491):1059–1062. doi: 10.1016/S0140-6736(05)67402-8.
   PubMed Web of Science ®Google Scholar
• Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Brück K, Jager KJ, Dounousi E, et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant. 2015;30(Suppl 4):iv6–16. doi: 10.1093/ndt/gfv131.
   PubMedGoogle Scholar
• Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured?. Ann Clin Biochem. 2009;46(Pt 3):205–217. doi: 10.1258/acb.2009.009007.
   PubMedGoogle Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi: 10.1016/S0140-6736(12)60033-6.
   PubMed Web of Science ®Google Scholar
• Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–114. doi: 10.1038/nrneph.2016.163.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar
• Oberg BP, McMenamin E, Lucas FL, et al. Increased pre­valence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65(3):1009–1016. doi: 10.1111/j.1523-1755.2004.00465.x.
   PubMed Web of Science ®Google Scholar
• Xu G, Luo K, Liu H, et al. The progress of inflammation and oxidative stress in patients with chronic kidney ­disease. Ren Fail. 2015;37(1):45–49. doi: 10.3109/0886022X.2014.964141.
   PubMed Web of Science ®Google Scholar
• Kwan BC, Kronenberg F, Beddhu S, et al. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol. 2007;18(4):1246–1261. doi: 10.1681/ASN.2006091006.
   PubMed Web of Science ®Google Scholar
• Xu L, Liu J, Li D, et al. Association between metabolic syndrome components and chronic kidney disease among 37,533 old Chinese individuals. Int Urol Nephrol. 2022;54(6):1445–1454. doi: 10.1007/s11255-021-03013-3.
   PubMed Web of Science ®Google Scholar
• Evangelopoulos AA, Vallianou NG, Bountziouka V, et al. Association between serum cystatin C, monocytes and other inflammatory markers. Intern Med J. 2012;42(5):517–522. doi: 10.1111/j.1445-5994.2011.02500.x.
   PubMed Web of Science ®Google Scholar
• Ganda A, Magnusson M, Yvan-Charvet L, et al. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis. Circulation. 2013;127(9):988–996. doi: 10.1161/CIRCULATIONAHA.112.000682.
   PubMed Web of Science ®Google Scholar
• Serin SO, Sisik A, Basak F. Relationship between monocyte-to-high-density lipoprotein cholesterol ratio and excess weight loss in laparoscopic sleeve gastrectomy. Biomark Med. 2021;15(15):1367–1375. doi: 10.2217/bmm-2021-0244.
   PubMed Web of Science ®Google Scholar
• Tang X, Tan Y, Yang Y, et al. Association of the monocyte-to-high-density lipoprotein cholesterol ratio with diabetic retinopathy. Front Cardiovasc Med. 2021;8:707008. doi: 10.3389/fcvm.2021.707008.
   PubMed Web of Science ®Google Scholar
• Yılmaz Aydın F, Eynel E, Oruç İ, et al. The role of monocyte to high-density lipoprotein cholesterol ratio in predicting the severity of proteinuria and renal dysfunction in primary nephrotic syndrome. Cureus. 2021;13(12):e20345. doi: 10.7759/cureus.20345.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619–1625. doi: 10.1007/s11255-014-0730-1.
   PubMed Web of Science ®Google Scholar
• Gembillo G, Siligato R, Cernaro V, et al. Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients. Int Urol Nephrol. 2022;54(2):395–403. doi: 10.1007/s11255-021-02904-9.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhong Z, Shi D, et al. Association between monocyte count to high-density lipoprotein cholesterol ratio and mortality in patients undergoing peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2021;31(7):2081–2088. doi: 10.1016/j.numecd.2021.03.014.
   PubMed Web of Science ®Google Scholar
• Zhan X, Pan D, Wei X, et al. Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2020;30(7):1130–1136. doi: 10.1016/j.numecd.2020.03.011.
   PubMed Web of Science ®Google Scholar
• Björkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630–1645. doi: 10.1016/j.cell.2022.04.004.
   PubMed Web of Science ®Google Scholar
• Rogacev KS, Ulrich C, Blömer L, et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J. 2010;31(3):369–376. doi: 10.1093/eurheartj/ehp308.
   PubMed Web of Science ®Google Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144–158. doi: 10.1038/s41581-019-0110-2.
   PubMed Web of Science ®Google Scholar
• Meng XM, Mak TS, Lan HY. Macrophages in renal fibrosis. Adv Exp Med Biol. 2019;1165:285–303. doi: 10.1007/978-981-13-8871-2_13.
   PubMed Web of Science ®Google Scholar
• Bell RMB, Conway BR. Macrophages in the kidney in health, injury and repair. Int Rev Cell Mol Biol. 2022;367:101–147. doi: 10.1016/bs.ircmb.2022.01.005.
   PubMedGoogle Scholar
• Noels H, Lehrke M, Vanholder R, et al. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nat Rev Nephrol. 2021;17(8):528–542. doi: 10.1038/s41581-021-00423-5.
   PubMed Web of Science ®Google Scholar
• Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol. 2016;12(1):37–47. doi: 10.1038/nrneph.2015.180.
   PubMed Web of Science ®Google Scholar
• Bowe B, Xie Y, Xian H, et al. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney Int. 2016;89(4):886–896. doi: 10.1016/j.kint.2015.12.034.
   PubMed Web of Science ®Google Scholar
• Patel VK, Williams H, Li SCH, et al. Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels. Atherosclerosis. 2017;263:15–23. doi: 10.1016/j.atherosclerosis.2017.05.026. PMID: 28570862.
   PubMed Web of Science ®Google Scholar
• Ganjali S, Gotto AM, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–9246. doi: 10.1002/jcp.27028.PMID: 30076716.
   PubMed Web of Science ®Google Scholar
• Liu Y, Coresh J, Eustace JA, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA. 2004;291(4):451–459. doi: 10.1001/jama.291.4.451.
   PubMed Web of Science ®Google Scholar
• Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957. doi: 10.1038/ki.2015.230.
   PubMed Web of Science ®Google Scholar
• Benghanem Gharbi M, Elseviers M, Zamd M, et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD. Kidney Int. 2016;89(6):1363–1371. doi: 10.1016/j.kint.2016.02.019.
   PubMed Web of Science ®Google Scholar
• White SL, Yu R, Craig JC, et al. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis. 2011;58(1):19–28. doi: 10.1053/j.ajkd.2010.12.026.
   PubMed Web of Science ®Google Scholar